American Association for the Study of Liver Diseases and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (AASLD/NASPGHAN) Course, Part 1—Getting to the Heart of the Matter: Navigating Fontan-Associated Liver Disease | AASLD

American Association for the Study of Liver Diseases and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (AASLD/NASPGHAN) Course, Part 1—Getting to the Heart of the Matter: Navigating Fontan-Associated Liver Disease

Nov 10 2025
Convention Center: Room 146C, Level 1
8:00 AM - 9:30 AM

World Class Speakers

Chaowapong Jarasvaraparn, MD
Presenter

Chaowapong Jarasvaraparn, MD

Riley Hospital for Children
Jordan S Sack, MD, MPH
Presenter

Jordan S Sack, MD, MPH

Brigham and Women's Hospital
Jonathan R Dillman, MD, MSc
Presenter

Jonathan R Dillman, MD, MSc

Cincinnati Children's Hospital Medical Center
Daniel Ganger, MD, FAASLD
Presenter

Daniel Ganger, MD, FAASLD

Northwestern Memorial Hospital
Ryan Fischer, MD
Presenter

Ryan Fischer, MD

Children's Mercy Hospital
Sindhu Pandurangi, MD, MS
Moderator

Sindhu Pandurangi, MD, MS

UT Southwestern, Children's Medical Center Dallas

Description

Hepatology, cardiology, and transplant medicine experts discuss the pathophysiology, clinical management, and long-term outcomes of Fontan-associated liver disease. The symposium highlights emerging research, diagnostic advancements, and multidisciplinary approaches to improve surveillance, treatment, and transplant decision-making for this unique patient population. Audience members learn from persuasive arguments by transplant surgeons regarding the options of isolated heart transplant versus combined heart-liver transplant for pediatric patients with Fontan failure. Attendees participate in this discussion by questioning presenters and voting how they would handle a challenging clinical case in light of the information presented.

 

Journey Maps

Presentations

8:00 AM - 8:15 AM
Oct 10 2026
Convention Center - Room 146C, Level 1

Fontan-Associated Liver Disease: Pathophysiology, Spectrum of Disease, Screening, and Biomarkers

Chaowapong Jarasvaraparn, MD , Presenter
Pediatrics
8:15 AM - 8:30 AM
Oct 10 2026
Convention Center - Room 146C, Level 1

Overview of Clinical Management of Fontan-Associated Liver Disease: Integrating Cardiology and Hepatology for Optimal Management and Surveillance

Jordan S Sack, MD, MPH , Presenter
Pediatrics
8:30 AM - 8:45 AM
Oct 10 2026
Convention Center - Room 146C, Level 1

Advances in Imaging Techniques in Fontan-Associated Liver Disease

Jonathan R Dillman, MD, MSc , Presenter
Pediatrics
8:45 AM - 8:57 AM
Oct 10 2026
Convention Center - Room 146C, Level 1

Pro: Arguing the Case for Combined Heart-Liver Transplant in Children and Young Adults

Daniel Ganger, MD, FAASLD , Presenter
Pediatrics
8:57 AM - 9:09 AM
Oct 10 2026
Convention Center - Room 146C, Level 1

Con: Arguing the Case for Isolated Heart Transplant in Fontan-Associated Liver Disease in Children and Young Adults

Ryan Fischer, MD , Presenter
Pediatrics
9:09 AM - 9:14 AM
Oct 10 2026
Convention Center - Room 146C, Level 1

Rebuttal

Daniel Ganger, MD, FAASLD , Presenter
Pediatrics
9:14 AM - 9:19 AM
Oct 10 2026
Convention Center - Room 146C, Level 1

Rebuttal

Ryan Fischer, MD , Presenter
Pediatrics

Objectives

  • Describe the pathophysiology and natural history of Fontan physiology.
  • Discuss screening, surveillance, diagnosis, and management strategies for the spectrum of Fontan-associated liver disease (FALD).
  • Review current and emerging diagnostic tools for FALD severity stratification.
  • Summarize the risks/benefits and medical/surgical decision-making regarding the roles of isolated heart transplantation versus combined heart-liver transplant in Fontan failure.
Chair

Debora Kogan-Liberman, MD

Hassenfeld Children's Hospital at NYU Langone